SEC Tracker
Get the app

City Therapeutics CTY

City Therapeutics amends corporate documents.

Item 5.03 Amends charter or bylaws

Form
8-K
Filed
Importance
Routine
  1. Authorized 500,000,000 shares of common stock.
  2. Eliminated references to preferred stock.
  3. Authorized 10,000,000 undesignated preferred shares.
  4. Removed stockholder written consent process.

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when City Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX